Showing 1 - 8 results of 8 for search 'Daniel Huertas', query time: 0.05s Refine Results
  1. 1
    Towards a future-proof climate database for European energy system studies

    Towards a future-proof climate database for European energy system studies by Laurent Dubus, David J Brayshaw, Daniel Huertas-Hernando, David Radu, Justin Sharp, William Zappa, Laurens P Stoop

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).

    Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine). by Mariana Muñoz-Esquerre, Elisabet Aliagas, Marta López-Sánchez, Ignacio Escobar, Daniel Huertas, Rosa Penín, Jordi Dorca, Salud Santos

    Published 2017-01-01
    Get full text
    Article
  3. 3
    High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study.

    High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study. by Marta López-Sánchez, Mariana Muñoz-Esquerre, Daniel Huertas, José Gonzalez-Costello, Jesús Ribas, Federico Manresa, Jordi Dorca, Salud Santos

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Correction: High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study.

    Correction: High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study. by Marta López-Sánchez, Mariana Muñoz-Esquerre, Daniel Huertas, José Gonzalez-Costello, Jesús Ribas, Federico Manresa, Jordi Dorca, Salud Santos

    Published 2014-01-01
    Get full text
    Article
  5. 5
    Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD

    Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD by Elisabet Aliagas, Mariana Muñoz-Esquerre, Ester Cuevas, Oriol Careta, Daniel Huertas, Marta López-Sánchez, Ignacio Escobar, Jordi Dorca, Salud Santos

    Published 2018-05-01
    Get full text
    Article
  6. 6
    Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.

    Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease. by Mariana Muñoz-Esquerre, Marta López-Sánchez, Ignacio Escobar, Daniel Huertas, Rosa Penín, María Molina-Molina, Frederic Manresa, Jordi Dorca, Salud Santos

    Published 2016-01-01
    Get full text
    Article
  7. 7
    Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations

    Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations by Ester Cuevas, Daniel Huertas, Concepción Montón, Alicia Marin, Alicia Marin, Anna Carrera-Salinas, Xavier Pomares, Marian García-Nuñez, Marian García-Nuñez, Sara Martí, Sara Martí, Salud Santos, Salud Santos

    Published 2023-07-01
    Get full text
    Article
  8. 8
    Genetic Adaptation and Acquisition of Macrolide Resistance in Haemophilus spp. during Persistent Respiratory Tract Colonization in Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Long-Term Azithromycin Treatment

    Genetic Adaptation and Acquisition of Macrolide Resistance in Haemophilus spp. during Persistent Respiratory Tract Colonization in Chronic Obstructive Pulmonary Disease (COPD) Pati... by Anna Carrera-Salinas, Aida González-Díaz, Rachel L. Ehrlich, Dàmaris Berbel, Fe Tubau, Xavier Pomares, Junkal Garmendia, M. Ángeles Domínguez, Carmen Ardanuy, Daniel Huertas, Alicia Marín, Conchita Montón, Joshua Chang Mell, Salud Santos, Sara Marti

    Published 2023-02-01
    Get full text
    Article

Search Tools: